Store the inhaler with the mouthpiece down ... Trial 3: Clinical Trial with Advair HFA 115 mcg/21 mcg Efficacy results in this trial were similar to those observed in Trials 1 and 2.

Even though Advair’s main patent expired in 2010 and the patent on the Diskus inhaler expired in 2016, until now no-one has managed to get the FDA to approve a cheaper copy of the drug-device ...

But this is likely only a stay of execution for Advair. It’s common for the FDA to reject generics, and with Mylan’s product there is the added complication of producing an inhaler device ...